These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1687681)

  • 1. Cholecystokinin (CCK) and schizophrenia: the selective CCKB antagonist LY262691 decreases midbrain dopamine unit activity.
    Rasmussen K; Stockton ME; Czachura JF; Howbert JJ
    Eur J Pharmacol; 1991 Dec; 209(1-2):135-8. PubMed ID: 1687681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrophysiological effects of diphenylpyrazolidinone cholecystokinin-B and cholecystokinin-A antagonists on midbrain dopamine neurons.
    Rasmussen K; Czachura JF; Stockton ME; Howbert JJ
    J Pharmacol Exp Ther; 1993 Jan; 264(1):480-8. PubMed ID: 8423546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of A9 and A10 dopamine cells by the cholecystokinin-B antagonist LY262691: mediation through feedback pathways from forebrain sites.
    Rasmussen K; Howbert JJ; Stockton ME
    Synapse; 1993 Oct; 15(2):95-103. PubMed ID: 8259526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The CCK-A receptor antagonist devazepide but not the CCK-B receptor antagonist L-365,260 reverses the effects of chronic clozapine and haloperidol on midbrain dopamine neurons.
    Minabe Y; Ashby CR; Wang RY
    Brain Res; 1991 May; 549(1):151-4. PubMed ID: 1893248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of acute and chronic LY 277359, a selective 5-HT3 receptor antagonist, on the number of spontaneously active midbrain dopamine neurons.
    Minabe Y; Ashby CR; Wang RY
    Eur J Pharmacol; 1991 Dec; 209(3):151-6. PubMed ID: 1797560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of the acute and chronic administration of CP 96,345, a selective neurokinin1 receptor antagonist, on midbrain dopamine neurons in the rat: a single unit, extracellular recording study.
    Minabe Y; Emori K; Toor A; Stutzmann GE; Ashby CR
    Synapse; 1996 Jan; 22(1):35-45. PubMed ID: 8822476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute and chronic administration of the selective 5-HT1A receptor antagonist WAY-405 significantly alters the activity of midbrain dopamine neurons in rats: an in vivo electrophysiological study.
    Minabe Y; Schechter L; Hashimoto K; Shirayama Y; Ashby CR
    Synapse; 2003 Dec; 50(3):181-90. PubMed ID: 14515335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the CCK-A receptor antagonist CR 1409 on the activity of rat midbrain dopamine neurons.
    Zhang J; Chiodo LA; Freeman AS
    Peptides; 1991; 12(2):339-43. PubMed ID: 2067986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population response of midbrain dopaminergic neurons to neuroleptics: further studies on time course and nondopaminergic neuronal influences.
    Chiodo LA; Bunney BS
    J Neurosci; 1987 Mar; 7(3):629-33. PubMed ID: 2881987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic BRL 43694, a selective 5-HT3 receptor antagonist, fails to alter the number of spontaneously active midbrain dopamine neurons.
    Ashby CR; Jiang LH; Wang RY
    Eur J Pharmacol; 1990 Jan; 175(3):347-50. PubMed ID: 2157603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CI-943, a potential antipsychotic agent. III. Evaluation of effects on dopamine neuronal activity.
    Meltzer LT; Christoffersen CL; Heffner TG; Freeman AS; Chiodo LA
    J Pharmacol Exp Ther; 1989 Oct; 251(1):123-30. PubMed ID: 2571714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrophysiological effects of BMY 14802, a new potential antipsychotic drug, on midbrain dopamine neurons in the rat: acute and chronic studies.
    Wachtel SR; White FJ
    J Pharmacol Exp Ther; 1988 Jan; 244(1):410-6. PubMed ID: 2891845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 5-HT3 receptor antagonist zatosetron decreases the number of spontaneously active A10 dopamine neurons.
    Rasmussen K; Stockton ME; Czachura JF
    Eur J Pharmacol; 1991 Nov; 205(1):113-6. PubMed ID: 1811993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible mechanisms by which repeated clozapine administration differentially affects the activity of two subpopulations of midbrain dopamine neurons.
    Chiodo LA; Bunney BS
    J Neurosci; 1985 Sep; 5(9):2539-44. PubMed ID: 2863337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Further studies on the specificity of proglumide as a selective cholecystokinin antagonist in the central nervous system.
    Bunney BS; Chiodo LA; Freeman AS
    Ann N Y Acad Sci; 1985; 448():345-51. PubMed ID: 2862828
    [No Abstract]   [Full Text] [Related]  

  • 16. Electrophysiological effects of E-5842, a sigma1 receptor ligand and potential atypical antipsychotic, on A9 and A10 dopamine neurons.
    Sánchez-Arroyos R; Guitart X
    Eur J Pharmacol; 1999 Jul; 378(1):31-7. PubMed ID: 10478562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spontaneous activity of A9 and A10 dopamine neurons after acute and chronic administration of the selective dopamine D-1 receptor antagonist SCH 23390.
    Goldstein JM; Litwin LC
    Eur J Pharmacol; 1988 Oct; 155(1-2):175-80. PubMed ID: 2907487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The orexin-1 receptor antagonist SB-334867 blocks the effects of antipsychotics on the activity of A9 and A10 dopamine neurons: implications for antipsychotic therapy.
    Rasmussen K; Hsu MA; Yang Y
    Neuropsychopharmacology; 2007 Apr; 32(4):786-92. PubMed ID: 17063151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of A9 and A10 dopaminergic neurons in unrestrained rats: further characterization and effects of apomorphine and cholecystokinin.
    Freeman AS; Bunney BS
    Brain Res; 1987 Mar; 405(1):46-55. PubMed ID: 3032350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrophysiological profile of the new atypical neuroleptic, sertindole, on midbrain dopamine neurones in rats: acute and repeated treatment.
    Skarsfeldt T
    Synapse; 1992 Jan; 10(1):25-33. PubMed ID: 1346943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.